Paired values of serum fructosamine and blood glucose for the screening of gestational diabetes mellitus: A retrospective study of 165 Saudi pregnant women

详细信息    查看全文

• 作者：Haseeb Ahmad Khan (1)
  Samia Hasan Sobki (2)
  Abdullah Saleh Alhomida (1)
  Shaukat Ali Khan (2)
  
• 关键词：Gestational diabetes mellitus ; Serum fructosamine ; Fasting blood glucose ; Random blood glucose
• 刊名：Indian Journal of Clinical Biochemistry
• 出版年：2007
• 出版时间：March 2007
• 年：2007
• 卷：22
• 期：1
• 页码：65-70
• 全文大小：82KB
• 参考文献：1. Kendrick JM. Preconception care of women with diabetes. J Perinat Neonat Nurs 2004;18:14-5.
  2. American Diabetic Association. Standards of medical care in diabetes. Diab Care 2004;27(Suppl 1):S15-S35.
  3. Catalano PM, Avallone DA, Drago NM, Amini SB. Reproducibility of the oral glucose tolerance test in pregnant women. Am J Obstet Gynecol 1993;169:874-1.
  4. Rey E, Hudon L, Michon N, Boucher P, Ethier J, Saint-Louis P. Fasting plasma glucose versus glucose challenge test: screening for gestational diabetes and cost effectiveness. Clin Biochem 2004;37:780-. CrossRef
  5. Lani S, Barrett D. The predictive value of the 1-h 50-g glucose screen for diagnosing gestational diabetes mellitus in a high-risk population. J Matern Fetal Neonat Med 2004;15:375-. CrossRef
  6. Perea-Carrasco R, Perez-Coronel R, Albusac-Aguilar R, Lombardo-grifol M, Bassas-Baena de Leon E, Romero-Diaz C. A simple index for detection of gestational diabetes mellitus. J R Soc Med 2002;95:435-. CrossRef
  7. Miyakoshi K, Tanaka M, Ueno K, Uehara K, Ishimoto H, Yoshimura Y. Cutoff value of 1 h, 50 g glucose challenge test for screening of gestational diabetes mellitus in a Japanese population. Diab Res Clin Pract 2003;60:63-. CrossRef
  8. Laird MD, McFarland MD, Face KF. Fasting blood glucose and initiation of insulin therapy in gestational diabetes. Endocr Pract 1996;2:330-.
  9. Hatem M, Dennis KJ. A random plasma glucose method for screening for abnormal glucose tolerance in pregnancy. Br J Obstet Gynaecol 1987;94:213-.
  10. Maheshwari JR, Mataliya MV. A random plasma glucose method for screening for gestational diabetes. J Postgr Med 1989;35:36-.
  11. Austin GE, Wheaton R, Nanes MS, Rubin J, Mullins RE. Usefulness of fructosamine for monitoring outpatients with diabetes. Am J Med Sci 1999;318:316-3. CrossRef
  12. Goldstein DE, Little RR, Wiedmeyer HM, England JD, McKenzie EM. Glycated hemoglobin: methodologies and clinical applications. Clin Chem 1986;32:B64-B70.
  13. Koskinen P, Irjala K, Viikari J, Panula-Ontto R, Matikainen MT. Serum fructosamine in the assessment of glycaemic control in diabetes mellitus. Scand J Clin Lab Invest 1987;47:285-2. CrossRef
  14. Peiris DS. The value of serum fructosamine in comparison with oral glucose tolerance test (OGTT) as a screening test for detection of gestational diabetes mellitus. J Obstet Gynaecol 2000;20:136-. CrossRef
  15. Hughes PF, Agarwal M, Newman P, Morrison J. An evaluation of fructosamine estimation in screening for gestational diabetes mellitus. Diabet Med 1995;12:708-2.
  16. Parfitt VJ, Clark JD, Turner GM, Hartog M. Use of fructosamine and glycated haemoglobin to verify self blood glucose monitoring data in diabetic pregnancy. Diab Med 1993;10:162-.
  17. Frandsen EK, Sabagh T, Bacchus RA. Serum fructosamine in diabetic pregnancy. Clin Chem 1988;34:316-.
  18. Roberts AB, Baker JR. Serum fructosamine: a screening test for diabetes in pregnancy. Am J Obstet Gynecol 1986;154:1027-0.
  19. Roberts AB, Baker JR, James AG, Henley P. Fructosamine in the management of gestational diabetes. Am J Obstet Gynecol 1988;159:66-1.
  20. Weerasekera DS, Peiris H. The value of serum fructos amine in comparison with oral glucose tolerance test (OGTT) as a screening test for detection of gestational diabetes mellitus. J Obstet Gynaecol 2000;20:136-. CrossRef
  21. Salemans TH, van Dieijen Visser MP, Brombacher PJ. The value of HbA1c and fructosamine in predicting impaired glucose tolerance—an alternative to OGTT to detect diabetes mellitus or gestational diabetes. Ann Clin Biochem 1987;24:447-2.
  22. Hom FG, Ettinger B, Lin MJ. Comparison of serum fructosamine vs glycohemoglobin as measures of glycemic control in a large diabetic population. Acta Diabetol 1998;35:48-1. CrossRef
  23. Mula Abed WA, Al Naemi AH. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus. Saudi Med J 2003;24:477-4.
  24. Kennedy DM, Johnson AB, Hill PG. A comparison of automated fructosamine and HbA1c methods for monitoring diabetes in pregnancy. Ann Clin Biochem 1998;35:283-.
  25. Agarwal MM, Punnose J. Screening for gestational diabetes in high-risk populations: the United Arab Emirates Experience. Annal Saudi Med 2001;21:117-.
  26. Laird MD, McFarland MD, Face KF. Fasting blood glucose and initiation of insulin therapy in gestational diabetes. Endocr Pract 1996;2:330-.
  27. Bhattacharya SM. Fasting or two-hour postprandial plasma glucose levels in early months of pregnancy as screening tools for gestational diabetes mellitus developing in later months of pregnancy. J Obstet Gynacol Res 2004;30:333-. CrossRef
  28. Cypryk K, Czupryniak L, Wilczynski J, Lewinski A. Diabetic screening after gestational diabetes mellitus: poor performance of fasting plasma glucose. Acta Diabetol 2004;41:5-. CrossRef
  29. Larsson H, Ahren B, Lindgrade F, Berglund G. Fasting blood glucose in determining the prevalence of diabetes in a large, homogeneous population of Caucasian middle-aged women. J Intern Med 1995;237:537-1.
  30. Perucchini D, Fischer U, Spinas GA, Huch R, Huch A, Lehmann R. Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study. Br Med J 1999;319:812-.
  31. Agarwal MM, Dhatt GS, Punnose J, Koster G. Gestational diabetes in a high-risk population: using the fasting plasma glucose to simplify the diagnostic algorithm. Eur J Obstet Gynecol Reprod Biol 2005;120:39-4. CrossRef
  32. Nasrat AA, Johnstone FD, Hasan SA. Is random plasma glucose an efficient screening test for abnormal glucose tolerance in pregnancy? Br J Obstet Gynaecol 1988;95:855-0.
  33. Nielsen IK, Vinther S, Birch K, Lange AP. Random blood glucose sampling as an early antenantal screening test for diabetes mellitus. Diab Res 1988;8:31-.
  34. Baker JR, O'Connor JP, Metcalf PA, Lawson MR, Johnson RN. Clinical usefulness of estimation of fructosamine concentration as a screening test for diabetes mellitus. Br Med J 1983;287:863-. CrossRef
  35. Bor MV, Bor P, Cevik C. Serum fructosamine and fructosamine-albumin ratio as screening tests for gestational diabetes mellitus. Arch Gynecol Obstet 1999;262:105-1. CrossRef
  36. Ko GTC, Chan JCN, Yeung VTF, et al. Combined use of fasting plasma glucose concentrations and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diab Care 1998;21:1221-. CrossRef
  37. Agarwal MM, Hughes PF, Punnose J, Ezimokhai M, Thomas L. Gestational diabetes screening of a multiethnic, high-risk population using glycated proteins. Diab Res Clin Pract 2001;51:67-3. CrossRef
  
• 作者单位：Haseeb Ahmad Khan (1)
  Samia Hasan Sobki (2)
  Abdullah Saleh Alhomida (1)
  Shaukat Ali Khan (2)
  
  1. Department of Biochemistry College of Science, King Saud University, Bld 5, Room 2A68, P.O. Box 2455, Riyadh, 11451, Saudi Arabia
  2. Division of Clinical Biochemistry, Department of Pathology, Armed Forces Hospital, Riyadh, Saudi Arabia
  

文摘

This study reports the utilization of serum fructosamine and blood glucose for the screening of gestational diabetes mellitus (GDM). Blood samples from 165 pregnant women were analyzed for fasting blood glucose (FBG), random blood glucose (RBG) and serum fructosamine. The actual fructosamine levels were corrected for serum protein (c-Fruct) for more precise presentation. Two cut-off values of FBG (>5.3 mmol/L and >7.0 mmol/L) and RBG (>7.8 mmol/L and >11.0 mmol/L) were used to classify hyperglycemic subjects for subsequent evaluation. The average values±standard deviations for FBG, RBG and cFruct were 5.865±1.95, 7.767±3.21 and 2.387±0.47 mmol/L, respectively. FBG levels were significantly correlated with RBG (Pearson correlation=0.597, P<0.001). Significant correlations were also observed between cFruct and FBG (Pearson correlation=0.673, P<0.001) or RBG (Pearson correlation=0.641, P<0.001). Out of 165 subjects, 24 (14.5%) cases were classified as hyperglycemic on the basis of FBG>7.0 mmol/L or RBG>11.0 mmol/L; use of lower cut-off values resulted higher frequencies of hyperglycemia. Whereas, a combined criteria of FBG>5.3 mmol/L and cFruct >2.5 mmol/L predicted 35 patients as the most probable hyperglycemic as compared to 32 patients identified using the criteria of RBG >7.8 mmol/L and cFruct >2.5 mmol/L. These criteria were associated with 4.8% and 3.6% false-positivity at the expense of 3.6% and 3.0% false-negative outcomes, respectively. The levels of FBG, RBG and cFruct were significantly higher in hyperglycemic groups (irrespective of grouping criteria) as compared to the respective normal groups. In conclusion, these findings clearly indicate that the paired values of cFruct with FBG or RBG could help in filtering high-risk individuals for OGTT and therefore avoiding a unnecessary OGTT.